USA CoVid "Vaccine" Death Totals by Age and Manufacturer 07/09/2021 VAERS Data X100 =1.14 Million Dead

For the Three Major Covid Vaccines using 07/09/2021 VAERS Data
using the Historical <1% Reporting Factor to the VAERS System these Numbers by Age Groups would be:
<3 Years 3 X100 = 300
12-17 Years 9 X100 = 900
17-44 Years 314 X100 = 31,400
44-65 Years 1,210 X100 = 121,000
65-75 Years 1,582 X100 = 158,200
75+ Years 4,244 X100 = 424,400
Unknown Age 4,134 X100 = 413,400
All Deaths 11,496 X100 = 1,149,600

Problems with the CDC VAERS "Passive" System
[link to www.bitchute.com (secure)]


-
But the Media would expose this Genocide Right?


[link to www.bitchute.com (secure)]
The Battle for Peoples Minds, Thoughts, lives and Work
POWER HUNGRY PEOPLE CONTROLLING THE NARRATIVE, THE SO CALLED ‘MOCKING BIRD’
First published at 05:57 UTC on August 19th, 2020.

Last Edited by CNews113p on 07/17/2021 10:40 AM

To get a Real World Number from the DataBase Numbers
Multiply the Database Number by 100, or just add two
zero's to their Number.

[link to www.medalerts.org (secure)]
Vaccine Type (COVID)
Vaccine Type SMQ Symptoms (Broad) Count Percent (SORTED HIGHEST TO LOWEST #)

[X]Expert Mode
[X]Show Table
and Symptoms SMQ (Broad)
(All Symptoms)
Vaccines: COVID19 (COVID-19)

VAERS Symptoms by Number

[link to www.medalerts.org (secure)]
Vaccine Type (COVID)
Vaccine Type SMQ Symptoms (Broad) Count Percent (SORTED HIGHEST TO LOWEST #)

SMQ Symptoms (Broad) Count Percent
TOTAL † 1,906,736 † 411.42%
Drug reaction with eosinophilia and systemic sy... 170,072 36.7%
Anticholinergic syndrome 147,414 31.81%
Neuroleptic malignant syndrome 129,195 27.88%
Anaphylactic reaction 112,702 24.32%
Tendinopathies and ligament disorders 75,701 16.33%
Hypoglycaemia 74,949 16.17%
Acute pancreatitis 70,019 15.11%
Guillain-Barre syndrome 69,624 15.02%
Extravasation events (injections, infusions and... 63,142 13.62%
Cardiomyopathy 57,728 12.46%
Noninfectious encephalopathy/delirium 52,961 11.43%
Vestibular disorders 52,630 11.36%
Noninfectious encephalitis 48,206 10.4%
Arrhythmia related investigations, signs and sy... 42,925 9.26%
Noninfectious meningitis 41,905 9.04%
Arthritis 39,334 8.49%
Rhabdomyolysis/myopathy 38,239 8.25%
Eosinophilic pneumonia 37,253 8.04%
Peripheral neuropathy 35,481 7.66%
Hypersensitivity 31,462 6.79%
Dementia 29,780 6.43%
Acute central respiratory depression 28,843 6.22%
Hypotonic-hyporesponsive episode 27,562 5.95%
Pulmonary hypertension 26,945 5.81%
Parkinson-like events 25,835 5.57%
Angioedema 25,464 5.49%
Dehydration 24,990 5.39%
Opportunistic infections 21,684 4.68%
COVID-19 21,515 4.64%
Torsade de pointes/QT prolongation 20,408 4.4%
Infective pneumonia 17,377 3.75%
Pseudomembranous colitis 16,466 3.55%
Hyperglycaemia/new onset diabetes mellitus 15,813 3.41%
Retroperitoneal fibrosis 15,674 3.38%
Dystonia 14,886 3.21%
Cardiac failure 13,196 2.85%
Gastrointestinal nonspecific symptoms and thera... 13,124 2.83%
Glaucoma 12,410 2.68%
Systemic lupus erythematosus 9,294 2.01%
Retinal disorders 9,165 1.98%
Generalised convulsive seizures following immun... 8,614 1.86%
Immune-mediated/autoimmune disorders 8,191 1.77%
Medication errors 7,255 1.57%
Lens disorders 6,939 1.5%
Depression (excl suicide and self injury) 5,688 1.23%
Hypokalaemia 4,864 1.05%
Respiratory failure 4,467 0.96%
Optic nerve disorders 4,403 0.95%
Hearing impairment 4,356 0.94%
Thrombophlebitis 4,276 0.92%
Gastrointestinal perforation, ulcer, haemorrhag... 4,234 0.91%
Asthma/bronchospasm 3,783 0.82%
Osteonecrosis 3,475 0.75%
Severe cutaneous adverse reactions 3,413 0.74%
Corneal disorders 3,403 0.73%
Conditions associated with central nervous syst... 3,069 0.66%
Dyskinesia 2,674 0.58%
Chronic kidney disease 2,589 0.56%
Fertility disorders 2,389 0.52%
Psychosis and psychotic disorders 2,202 0.48%
Akathisia 2,115 0.46%
Haemorrhage laboratory terms 2,110 0.46%
Tumour lysis syndrome 2,023 0.44%
Torsade de pointes, shock-associated conditions 1,971 0.43%
Hypoglycaemic and neurogenic shock conditions 1,953 0.42%
Hypovolaemic shock conditions 1,948 0.42%
Anaphylactic/anaphylactoid shock conditions 1,940 0.42%
Toxic-septic shock conditions 1,914 0.41%
Hostility/aggression 1,827 0.39%
Shock-associated circulatory or cardiac conditi... 1,818 0.39%
Drug abuse and dependence 1,569 0.34%
Ischaemic colitis 1,371 0.3%
Lipodystrophy 1,363 0.29%
Haematopoietic erythropenia 939 0.2%
Accidents and injuries 859 0.19%
Acute renal failure 765 0.17%
Noninfectious diarrhoea 702 0.15%
Tubulointerstitial diseases 603 0.13%
Ocular motility disorders 556 0.12%
Hypertension 544 0.12%
Ocular infections 517 0.11%
Agranulocytosis 469 0.1%
Hypothyroidism 464 0.1%
Hyperthyroidism 441 0.1%
Myocardial infarction 399 0.09%
Haematopoietic leukopenia 386 0.08%
Sepsis 363 0.08%
Osteoporosis/osteopenia 349 0.08%
Other ischaemic heart disease 285 0.06%
Biliary system related investigations, signs an... 273 0.06%
Gastrointestinal nonspecific inflammation 269 0.06%
Myelodysplastic syndrome 225 0.05%
Convulsions 198 0.04%
Lactic acidosis 186 0.04%
Demyelination 154 0.03%
Gastrointestinal nonspecific dysfunction 153 0.03%
Interstitial lung disease 150 0.03%
Hyponatraemia/SIADH 146 0.03%
Haematopoietic cytopenias affecting more than o... 96 0.02%
Liver related investigations, signs and symptoms 91 0.02%
Malignant lymphomas 70 0.02%
Proteinuria 69 0.01%
Renovascular disorders 66 0.01%
Skin tumours of unspecified malignancy 60 0.01%
Vasculitis 48 0.01%

Last Edited by CNews113p on 07/16/2021 07:49 PM

19m53s
[link to www.bitchute.com (secure)]


COVID 'SPIKE PROTEIN' TRANSMISSION - MAGNETISM

Drug reaction with eosinophilia and systemic sy... 170,072 36.7%

Eosinophilia

[link to my.clevelandclinic.org (secure)]

Eosinophilia
Having a high number of eosinophils, a specific type of white blood cell, is called eosinophilia. It can be caused by common things

like nasal allergy or more serious conditions, such as cancer. It is discovered by blood testing.
APPOINTMENTS & ACCESS
CONTACT US
Symptoms and Causes Diagnosis and Tests Management and Treatment Outlook / Prognosis
OVERVIEW
What is eosinophilia?
Eosinophilia refers to a condition of having an increased numbers of eosinophils in the peripheral blood. White blood cells are an

essential component of the cellular immune system. Eosinophils are specific white blood cells that are a normal part of the cellular immune system, play a role in normal physiologic processes and host defense, and participate in allergic reactions and the defense
against parasitic infections.

Eosinophilia is said to occur when there are greater than 500 eosinophils per microliter, though the exact cutoff varies by

laboratory. Eosinophilia can be considered mild, moderate or severe. Usually, less than 5% of the circulating white blood cells in a person are eosinophils.

SYMPTOMS AND CAUSES
What causes eosinophilia?
Causes range from less serious but very common conditions such as nasal allergy and asthma to more serious hematologic conditions,

including:

Allergies and asthma
Drug allergy
Infections (mostly from parasites)
Blood disorders and cancers
Autoimmune disease
Endocrine disorders
Diseases involving organs and systems, including the:
Skin
Lungs
Gastrointestinal system
Neurological system
Joints, muscles and connective tissue
Heart
Eosinophilic disorders are often called by names that reflect where the problem is located. These include:

Eosinophilic cystitis, a disorder of the bladder
Eosinophilic fasciitis, a disorder of the fascia, or the connective tissue throughout the body
Eosinophilic pneumonia, a disorder of the lungs
Eosinophilic colitis, a disorder of the colon (large intestine)
Eosinophilic esophagitis, a disorder of the esophagus
Eosinophilic gastritis, a disorder of the stomach
Eosinophilic gastroenteritis, a disorder of both the stomach and the small intestine
The last four types on the list are known as eosinophilic gastrointestinal disorders (EGIDs). This category of disease is

increasing. Eosinophilic granulomatosis with polyangiitis involves the lungs, heart, sinuses, and other organs. It is also known as

Churg-Strauss syndrome. Another condition is hypereosinophilic syndrome, which is a primary hematologic disorder involving the blood

and other organs.

DIAGNOSIS AND TESTS
How is eosinophilia diagnosed?
Elevated peripheral blood eosinophils can be found during blood testing. Depending on what the cause could be, your doctor might

order more tests. Other tests might include:

Liver function tests
Chest X-rays
Urine tests
Further blood tests
Tissue and bone marrow biopsies
Stool sample testing
MANAGEMENT AND TREATMENT
How is eosinophilia treated?
Treatment depends on the cause of the condition. Treatments might include stopping certain medications (in the case of drug

reactions), avoiding certain foods (in the case of esophagitis), or taking an anti-infective or anti-inflammatory medication.

Treatments that target eosinophils in asthma specifically have been approved by the Food & Drug Administration (FDA) and are being

used in the clinic, while treatments for other eosinophil-mediated conditions are under further investigation.

OUTLOOK / PROGNOSIS
What is the outlook for eosinophilia?
Treating the cause of high eosinophil counts affects the outcome. In more serious conditions, outcomes also depend on the extent of

target organ and how the person responds to treatment.

Last reviewed by a Cleveland Clinic medical professional on 02/15/2018.

Anticholinergic syndrome 147,414 31.81%

[link to www.sciencedirect.com (secure)]

Anticholinergic Syndrome
Central anticholinergic syndrome refers to an acute psychosis or delirium resulting from inhibition of central cholinergic transmission.

From: Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose (Fourth Edition), 2007

Related terms:
Delirium
Parasympatholytic
Scopolamine
Atropine
Physostigmine
Ingestion
Naloxone
Agitation
Toxicity
Intoxication

Neuroleptic malignant syndrome 129,195 27.88%

[link to rarediseases.org (secure)]

Rare Disease Database
Neuroleptic Malignant Syndrome
Synonyms of Neuroleptic Malignant Syndrome
Drug-Induced Movement Disorder
Hyperthermia
Neuroleptic-Induced Acute Dystonia
General Discussion
Neuroleptic malignant syndrome is a rare but potentially life-threatening reaction to the use of almost any of a group of antipsychotic drugs or major tranquilizers (neuroleptics). These drugs are commonly prescribed for the treatment of schizophrenia and other neurological, mental, or emotional disorders. Several of the more commonly prescribed neuroleptics include thioridazine, haloperidol, chlorpromazine, fluphenazine and perphenazine.

The syndrome is characterized by high fever, stiffness of the muscles, altered mental status (paranoid behavior), and autonomic dysfunction. Autonomic dysfunction alludes to defective operations of the components of the involuntary (autonomic) nervous system, leading to wide swings of blood pressure, excessive sweating and excessive secretion of saliva.

A genetic basis for the disorder is suspected but not proven. It does appear to be clear that a defect in the receptors to dopamine (dopamine D2 receptor antagonism) is an important contributor to the cause of neuroleptic malignant syndrome.

Signs & Symptoms
Symptoms of neuroleptic malignant syndrome usually include very high fever (102 to 104 degrees F), irregular pulse, accelerated heartbeat (tachycardia), increased rate of respiration (tachypnea), muscle rigidity, altered mental status, autonomic nervous system dysfunction resulting in high or low blood pressure, profuse perspiration, and excessive sweating.

Other symptoms may include liver or kidney failure, abnormally high potassium levels (hyperkalemia), major destruction of skeletal muscle tissue (rhabdo-myolysis) or blood clots in veins and arteries.

Causes
Neuroleptic malignant syndrome comes about, most likely, as a result of “dopamine D2 receptor antagonism”. Dopamine is a chemical substance (neurotransmitter) found in the brain and elsewhere in the central nervous system that acts to convey messages from one cell to another. In some way, the use of a particular drug blocks the receptor in the brain cell for dopamine.

When the dopamine receptors in the hypothalamus or another bundle of nerve fibers (nigrostriatal pathways) and/or the spinal cord are blocked, increased muscle rigidity is the result. The interference with the dopamine receptors in the hypothalamus is also probably responsible for high body temperature, as well as the swings in blood pressure.

Some clinicians believe that neuroleptic malignant syndrome may be related to malignant hyperthermia, a genetic disorder characterized by an abnormal reaction to anesthesia drugs. (See related disorders section for more information about malignant hyperthermia.)

Affected Populations
Neuroleptic malignant syndrome may affect any person taking neuroleptic drugs. Men appear to be at higher risk than women. Some clinicians believe that the stronger neuroleptic medications are more likely to precipitate an attack of NMS.

Although two-thirds of cases are thought to occur within the first week of start of treatment, the syndrome may begin at any time during treatment.

Recurrence of an attack of NMS is not uncommon. The risk of recurrence is closely related to the time elapsed between the end of the original episode of neuroleptic malignant syndrome and the beginning of renewed administration of an antipsychotic drug. If the waiting period is two weeks or less, about 63% will have a recurrence. If the waiting period is more than two weeks, the percentage of patients experiencing a relapse drops to about 30.

Related Disorders
Symptoms of the following disorders can be similar to those of neuroleptic malignant syndrome. Comparisons may be useful for a differential diagnosis:

Anaphylaxis is an abnormally severe allergic reaction to a substance. Major symptoms may include severe itching, hives, flushing, swelling, vomiting, diarrhea, difficulty breathing and unconsciousness. High fever is not a symptom of this disorder. (For more information on this disorder, choose “Anaphylaxis” as your search term in the Rare Disease Database.)

Lethal catatonia is a condition similar to NMS and not infrequently confused with it. A detailed history may indicate that the patient has endured catatonic states while not on neuroleptic medications. If so, the chances are that the presenting syndrome is NMS. A lethal catatonia patient will respond to the administration of neuroleptics. It is, however, almost impossible to predict whether the patient’s symptoms will worsen or improve. Patients with lethal catatonia almost invariably endure a period of agitation and excitement prior to the catatonia. This is in contrast to the patient with NMS in which the first symptom is usually muscular rigidity.

Heat stroke is a very serious condition characterized by an abrupt and rapid increase in body temperature that may reach as high as 104 to 106 degrees F. Heat stroke usually results from exposure to an extremely hot environment. The skin may become hot, flushed and dry. Rapid loss of fluids may result in the inability to sweat. Sweating is necessary to cool the body. There may also be an increase in pulse rate and respiration. The affected individual may become disoriented and eventually experience convulsions or slip into unconsciousness. Measures such as wrapping the individual in cold, wet sheets should be taken immediately to lower body temperature. An individual suffering from heat stroke should be hospitalized as quickly as possible. (For more information on this disorder, choose “Hyperthermia” as your search term in the Rare Disease Database.)

Malignant hyperthermia is a genetic disorder characterized by an abnormal response to muscle relaxants and general anesthesia drugs. Symptoms of Malignant Hyperthermia are apparent only after the patient has been placed under general anesthesia. Along with rapidly elevating body temperature that may rise as high as 110 degrees, muscle rigidity and/or muscle twitching occurs. The patient may also exhibit a very rapid and irregular heartbeat, abnormally low blood pressure, sickly sweet breath, headache, nausea and vomiting. It is not known whether neuroleptic malignant hyperthermia is a variant form of Malignant Hyperthermia, but some researchers have suggested that these disorders may be related. (For more information on this disorder, choose “Malignant Hyperthermia” as your search term in the Rare Disease Database.)

The serotonin syndrome mimics neuroleptic malignant hyperthermia. If the use of selective serotonin reuptake inhibitors (SSRIs) results in symptoms such as altered mental state, autonomic dysfunction (see above), and neuromuscular defects, then the condition is likely to be serotonin syndrome. Since SSRIs are being used in increasing amounts, it is not unreasonable to expect that the incidence of serotonin syndrome will increase as well. The serotonin syndrome may be distinguished from NMS in most cases by a detailed history in which any changes in medication and/or dosages are clarified. In addition, serotonin syndrome usually is not accompanied by severe muscle rigidity.

The following disorder may be associated with the extended use of neuroleptic drugs. It is not necessary for a differential diagnosis:

Tardive dyskinesia is a disorder that results from the long-term use of neuroleptic drugs and is characterized by involuntary and abnormal movements of the jaw, lips and tongue. Typical symptoms include grimacing, sticking out the tongue, and sucking or fishlike movements of the mouth. A high percentage of schizophrenic people who have spent long periods of time in mental hospitals taking neuroleptic drugs have a high risk of developing tardive dyskinesia. (For more information on this disorder, choose “tardive dyskinesia” for your search term in the Rare Disease Database.)

Diagnosis
The diagnosis of neuroleptic malignant syndrome is based on the presence of characteristics that include treatment with neuroleptic drugs within the past 1-4 weeks. high body temperature (greater than 38 degrees centigrade); muscle rigidity; and at least five of the following:

-Change in mental status
-Rapid heart beat (tachycardia)
-Low or high blood pressure (hypo- or hypertension)
-Excessive sweating (diaphoresis)
-Excessive saliva production (sialorrhea)
-Tremor
-Incontinence
-Increased creatine phosphokinase, or increased urinary myoglobin
-Increased number of white blood cells (leukocytosis)
-Increased concentrations of metabolic acids in blood and urine
-Exclusion of other drug-induced psychiatric or systemic illness.

Standard Therapies
Treatment

Treatment of neuroleptic malignant syndrome consists of withdrawal of

neuroleptic medications under a doctor's supervision, immediate measures to restore appropriate water and nutrient levels, and steps to lower the individual's body temperature. Medications prescribed as treatment may include skeletal muscle relaxants, such as dantrolene; stimulators of dopamine production and activity, such as bromocriptine; and/or continuous perfusion of central nervous system depressants, such as diazepam.

Complications that may result from neuroleptic malignant syndrome, such as kidney (renal) insufficiency, deficiency of oxygen reaching the tissues (hypoxia), and/or decreased alkalinity of the blood and tissues (acidosis) can be extremely serious and must be treated immediately. Once patients have recovered from neuroleptic malignant syndrome, about 87% will be able to tolerate an antipsychotic at some point in the future. Physicians usually switch to a different antipsychotic class and to an atypical antipsychotic. Such patients must be carefully monitored since recurrences of neuroleptic malignant syndrome are not infrequent.

Electroconvulsive treatments have been prescribed for patients with neuroleptic malignant syndrome with varied results.

Anaphylactic reaction

[link to www.mayoclinic.org (secure)]

Anaphylaxis

Overview
Anaphylaxis is a severe, potentially life-threatening allergic reaction. It can occur within seconds or minutes of exposure to something you're allergic to, such as peanuts or bee stings.

Anaphylaxis causes your immune system to release a flood of chemicals that can cause you to go into shock — your blood pressure drops suddenly and your airways narrow, blocking breathing. Signs and symptoms include a rapid, weak pulse; a skin rash; and nausea and vomiting. Common triggers include certain foods, some medications, insect venom and latex.

Anaphylaxis requires an injection of epinephrine and a follow-up trip to an emergency room. If you don't have epinephrine, you need to go to an emergency room immediately. If anaphylaxis isn't treated right away, it can be fatal.

Products & Services
Book: Mayo Clinic Family Health Book, 5th Edition
Show more products from Mayo Clinic
Symptoms
Anaphylaxis symptoms usually occur within minutes of exposure to an allergen. Sometimes, however, it can occur a half-hour or longer after exposure. Signs and symptoms include:

Skin reactions, including hives and itching and flushed or pale skin
Low blood pressure (hypotension)
Constriction of your airways and a swollen tongue or throat, which can cause wheezing and trouble breathing
A weak and rapid pulse
Nausea, vomiting or diarrhea
Dizziness or fainting
When to see a doctor
Seek emergency medical help if you, your child or someone else you're with has a severe allergic reaction. Don't wait to see if the symptoms go away.

If the person having the attack carries an epinephrine autoinjector, administer it right away. Even if symptoms improve after the injection, you still need to go to an emergency room to make sure symptoms don't recur, even without more exposure to your allergen. This second reaction is called biphasic anaphylaxis.

Tendinopathies and ligament disorders 75,701 16.33%

[link to www.mltj.online]

Editorial Metabolic diseases and tendinopathies: the ...
Search domain mltj.onlinewww.mltj.online/wp-content/uploads/2019/01/Metabol​ic-diseases-and-tendinopathies-the-missing-link.pdf
rum "Metabolic diseases and tendinopathies: the missing link", held on 21 June 2014 at the Università della Svizzera Italiana in Lugano, Switzerland. The forum brought together some 200 members of the international scientific community, including physician and surgeons, basic scientists, physiotherapist, sports

Hypoglycaemia 74,949 16.17%

[link to www.mayoclinic.org (secure)]

Hypoglycemia

Overview
Hypoglycemia is a condition in which your blood sugar (glucose) level is lower than normal. Glucose is your body's main energy source.

Hypoglycemia is often related to diabetes treatment. But other drugs and a variety of conditions — many rare — can cause low blood sugar in people who don't have diabetes

Hypoglycemia needs immediate treatment when blood sugar levels are low. For many people, a fasting blood sugar of 70 milligrams per deciliter (mg/dL), or 3.9 millimoles per liter (mmol/L), or below should serve as an alert for hypoglycemia. But your numbers might be different. Ask your doctor.

Treatment involves quickly getting your blood sugar back to normal either with high-sugar foods or drinks or with medications. Long-term treatment requires identifying and treating the cause of hypoglycemia.

Products & Services
Book: Mayo Clinic Family Health Book, 5th Edition
Show more products from Mayo Clinic
Symptoms
If blood sugar levels become too low, signs and symptoms can include:

An irregular or fast heartbeat
Fatigue
Pale skin
Shakiness
Anxiety
Sweating
Hunger
Irritability
Tingling or numbness of the lips, tongue or cheek
As hypoglycemia worsens, signs and symptoms can include:

Confusion, abnormal behavior or both, such as the inability to complete routine tasks
Visual disturbances, such as blurred vision
Seizures
Loss of consciousness
When to see a doctor
Seek a doctor's help immediately if:

You have what might be hypoglycemia symptoms and you don't have diabetes
You have diabetes and hypoglycemia isn't responding to treatment, such as drinking juice or regular soft drinks, eating candy, or taking glucose tablets
Seek emergency help for someone with diabetes or a history of hypoglycemia who has symptoms of severe hypoglycemia or loses consciousness.

Acute pancreatitis 70,019 15.11%

[link to www.mayoclinic.org (secure)]

Pancreatitis

Overview
Pancreatitis caused by gallstones
Pancreatitis caused by gallstones Open pop-up dialog box
Pancreatitis is inflammation in the pancreas. The pancreas is a long, flat gland that sits tucked behind the stomach in the upper abdomen. The pancreas produces enzymes that help digestion and hormones that help regulate the way your body processes sugar (glucose).

Pancreatitis can occur as acute pancreatitis — meaning it appears suddenly and lasts for days. Or pancreatitis can occur as chronic pancreatitis, which is pancreatitis that occurs over many years.

Mild cases of pancreatitis may go away without treatment, but severe cases can cause life-threatening complications.

Guillain-Barre syndrome 69,624 15.02%

[link to www.mayoclinic.org (secure)]

Guillain-Barre syndrome

Overview
Nerve and damaged myelin sheath
Nerve and damaged myelin sheath Open pop-up dialog box
Guillain-Barre (gee-YAH-buh-RAY) syndrome is a rare disorder in which your body's immune system attacks your nerves. Weakness and tingling in your extremities are usually the first symptoms.

These sensations can quickly spread, eventually paralyzing your whole body. In its most severe form Guillain-Barre syndrome is a medical emergency. Most people with the condition must be hospitalized to receive treatment.

The exact cause of Guillain-Barre syndrome is unknown. But two-thirds of patients report symptoms of an infection in the six weeks preceding. These include respiratory or a gastrointestinal infection or Zika virus.

There's no known cure for Guillain-Barre syndrome, but several treatments can ease symptoms and reduce the duration of the illness. Although most people recover from Guillain-Barre syndrome, the mortality rate is 4% to 7%. Between 60-80% of people are able to walk at six months. Patients may experience lingering effects from it, such as weakness, numbness or fatigue.

Products & Services
Book: Mayo Clinic Family Health Book, 5th Edition
Show more products from Mayo Clinic
Symptoms
Guillain-Barre syndrome often begins with tingling and weakness starting in your feet and legs and spreading to your upper body and arms. In about 10% of people with the disorder, symptoms begin in the arms or face. As Guillain-Barre syndrome progresses, muscle weakness can evolve into paralysis.

Signs and symptoms of Guillain-Barre syndrome may include:

Prickling, pins and needles sensations in your fingers, toes, ankles or wrists
Weakness in your legs that spreads to your upper body
Unsteady walking or inability to walk or climb stairs
Difficulty with facial movements, including speaking, chewing or swallowing
Double vision or inability to move eyes
Severe pain that may feel achy, shooting or cramplike and may be worse at night
Difficulty with bladder control or bowel function
Rapid heart rate
Low or high blood pressure
Difficulty breathing
People with Guillain-Barre syndrome usually experience their most significant weakness within two weeks after symptoms begin.

Types
Once thought to be a single disorder, Guillain-Barre syndrome is now known to occur in several forms. The main types are:

Acute inflammatory demyelinating polyradiculoneuropathy (AIDP), the most common form in North America and Europe. The most common sign of AIDP is muscle weakness that starts in the lower part of your body and spreads upward.
Miller Fisher syndrome (MFS), in which paralysis starts in the eyes. MFS is also associated with unsteady gait. MFS is less common in the U.S. but more common in Asia.
Acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN) are less common in the U.S. But AMAN and AMSAN are more frequent in China, Japan and Mexico.
When to see a doctor
Call your doctor if you have mild tingling in your toes or fingers that doesn't seem to be spreading or getting worse. Seek emergency medical help if you have any of these severe signs or symptoms:

Tingling that started in your feet or toes and is now moving up your body
Tingling or weakness that's spreading rapidly
Difficulty catching your breath or shortness of breath when lying flat
Choking on saliva
Guillain-Barre syndrome is a serious condition that requires immediate hospitalization because it can worsen rapidly. The sooner appropriate treatment is started, the better the chance of a good outcome.

Request an Appointment at Mayo Clinic
Causes
The exact cause of Guillain-Barre syndrome isn't known. The disorder usually appears days or weeks after a respiratory or digestive tract infection. Rarely, recent surgery or vaccination can trigger Guillain-Barre syndrome. Recently, there have been cases reported following infection with the Zika virus. Guillain-Barre syndrome may also occur after infection with the COVID-19.

In Guillain-Barre syndrome, your immune system — which usually attacks only invading organisms — begins attacking the nerves. In AIDP, the most common form of Guillain-Barre syndrome in the U.S., the nerves' protective covering (myelin sheath) is damaged. The damage prevents nerves from transmitting signals to your brain, causing weakness, numbness or paralysis.

Risk factors
Guillain-Barre syndrome can affect all age groups. But your risk increases as you age. It's also more common in males than females.

Guillain-Barre syndrome may be triggered by:

Most commonly, infection with campylobacter, a type of bacteria often found in undercooked poultry
Influenza virus
Cytomegalovirus
Epstein-Barr virus
Zika virus
Hepatitis A, B, C and E
HIV, the virus that causes AIDS
Mycoplasma pneumonia
Surgery
Trauma
Hodgkin's lymphoma
Rarely, influenza vaccinations or childhood vaccinations
COVID-19
Complications
Guillain-Barre syndrome affects your nerves. Because nerves control your movements and body functions, people with Guillain-Barre may experience:

Breathing difficulties. The weakness or paralysis can spread to the muscles that control your breathing, a potentially fatal complication. Up to 22% of people with Guillain-Barre syndrome need temporary help from a machine to breathe within the first week when they're hospitalized for treatment.
Residual numbness or other sensations. Most people with Guillain-Barre syndrome recover completely or have only minor, residual weakness, numbness or tingling.
Heart and blood pressure problems. Blood pressure fluctuations and irregular heart rhythms (cardiac arrhythmias) are common side effects of Guillain-Barre syndrome.
Pain. One-third of people with Guillain-Barre syndrome experience severe nerve pain, which may be eased with medication.
Bowel and bladder function problems. Sluggish bowel function and urine retention may result from Guillain-Barre syndrome.
Blood clots. People who are immobile due to Guillain-Barre syndrome are at risk of developing blood clots. Until you're able to walk independently, taking blood thinners and wearing support stockings may be recommended.
Pressure sores. Being immobile also puts you at risk of developing bedsores (pressure sores). Frequent repositioning may help avoid this problem.
Relapse. From 2% to 5% of people with Guillain-Barre syndrome experience a relapse.
Severe, early symptoms of Guillain-Barre syndrome significantly increase the risk of serious long-term complications. Rarely, death may occur from complications such as respiratory distress syndrome and heart attacks.

so while they vilify JNJ in the press, it actually has the lowest morbidity.

go figure.

You are like Cuomo on steroids except he subtracts, you multiply. Why the fake numbers ? Do you feel the need to bolster your opinions with fake numbers ?

RE: so while they vilify JNJ in the press, it actually has the lowest morbidity.

The NWO is pushing hard to get everyone the
DNA Changing Shots. There is not Cure for putting BAD Code into your DNA.

well I had to get the jab for my job
so I got the JNJ.

lesser of the 3 evils in my book.

The Lesser of 3 evils is still Evil.

Why not Try Good, instead of Evil?
Thread: PLEASE PIN - The BEST religious exemption form for employer mandated Covid Vaccine! Your life may depend on this!
PLEASE PIN - The BEST religious exemption form for employer mandated Covid Vaccine! Your life may depend on this!
07/14/2021 11:46 PM

Now use the same ratio for a projection for the global total if everyone was 'jabbed'. 350M to 7B ratio.
Just NATO aligned countries would also allow projecting how much in loans the WB has given out. (2018-2019 budgets compared to 2020-2021)

It seems odd that Pfizer has so many Deaths with an unknown
age, compared with Moderna that should have similar numbers
in the Database.
Pfizer: Unknown Age 3,815
Moderna: Unknown Age 164

Just face it.

We are all FUCKED.

THE PLAN

[link to www.godlikeproductions.com]

Vax is proven safe.

[link to www.godlikeproductions.com]



Vax is new strain

Thread: The vax IS THE NEW STRAIN PROOF...ABSOLUTE PROOF.

The "Cure" is the Dis-EASE.

Updated

How could the Media Not Report this Genocide?

2m26s
[link to www.bitchute.com (secure)]

CONSPIRACY THEORY ROCK - A BANNED SEGMENT FROM SATURDAY NIGHT LIVE
First published at 16:20 UTC on April 12th, 2019.
#DIANEDI #CONSPIRACYTHEORYROCK #MEDIA
DianeDi

backup links:
[link to www.bitchute.com (secure)]

[link to www.bitchute.com (secure)]

Related but different video:

1m38s
[link to www.bitchute.com (secure)]
IS THIS THE END OF CBS, FOX, NBC, AND ABC
First published at 00:56 UTC on January 3rd, 2021.
#NWO #MSM #PROPAGANDA
Conservative Politics and anti-NWO, anti-nazi/left
Starblazer692003

backup link:
[link to www.bitchute.com (secure)]

1m38s
[link to www.bitchute.com (secure)]

IS THIS THE END OF CBS, FOX, NBC, AND ABC
First published at 00:56 UTC on January 3rd, 2021.
#NWO #MSM #PROPAGANDA
Conservative Politics and anti-NWO, anti-nazi/left
Starblazer692003

backup link:
[link to www.bitchute.com (secure)]

[link to www.bitchute.com (secure)]
The Battle for Peoples Minds, Thoughts, lives and Work
POWER HUNGRY PEOPLE CONTROLLING THE NARRATIVE, THE SO CALLED ‘MOCKING BIRD’
First published at 05:57 UTC on August 19th, 2020.

FEMA DRILL ON 9-10-2001 DAY BEFORE 911
2m42s
[link to youtu.be (secure)]

DRILL ON 9-10-2001 DAY BEFORE 911

==============
FULL CBS CLIP
[link to www.bitchute.com (secure)]

TOM KENNEY, FEMA, ARRIVED IN N.Y. ON MONDAY 9/10 FOR THE 9/11 EVENTS ...
First published at 00:08 UTC on September 8th, 2019.
MAGA
On September 13 in 2001, Dan Rather interviewed Tom Kenney for the FEMA Urban Search & Rescue team.
During that short interview, at the 2 minute mark (2:00), Mister Kenney unwillingly blows the whistle about the "inside job".
He says : "To be honest with you, we arrived on late Monday night, and went into action on Tuesday morning".

Last Edited by CNews113p on 07/17/2021 11:57 AM